Pre-XDR spinal tuberculosis and 360° approach in two surgical times: a case report

BACKGROUND: Spinal tuberculosis (STB), or Pott’s disease, is a relatively frequent form of extrapulmonary involvement representing 50% of bone tuberculosis. Its diagnosis continues to be challenging due to the insidious presentation of the condition and is essential because it can cause disability d...

Full description

Bibliographic Details
Published in:	Infectious Diseases and Tropical Medicine
Main Authors:	C. Montero-Silva, F. Alvarado-Gómez, M. Herrera-Mendez, F. Soto-Guzman, N. Aborashed-Amador, A. Tristancho, M. Giraldo-Bernal
Format:	Article
Language:	English
Published:	Verduci Editore 2023-01-01
Subjects:	pott's disease spinal tuberculosis xdr-tb
Online Access:	https://www.infectiousjournal.com/wp-content/uploads/sites/6/2023/01/27507-e1058.pdf

Similar Items

Prevalence of Pre-Extensively Drug-Resistant Tuberculosis (Pre XDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) at a Tertiary Care Center in Mumbai
by: Unnati D. Desai, et al.
Published: (2016-07-01)

Impacts of MDR/XDR-TB on the global tuberculosis epidemic: Challenges and opportunities
by: Kai Ling Chin, et al.
Published: (2024-01-01)

Tuberculosis extremadamente resistente (TB-XDR), historia y situación actual
by: Alberto Mendoza Ticona, et al.
Published: (2018-06-01)

Challenges and controversies in the treatment of spinal tuberculosis
by: Aakriti Pandita, et al.
Published: (2020-05-01)

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
by: Isabelle Bonnet, et al.
Published: (2022-06-01)

XDR TB in South Africa - What lies ahead?
by: V. Thaver, et al.
Published: (2007-12-01)

Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China
by: Zhang P, et al.
Published: (2022-05-01)

The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
by: Heidary M, et al.
Published: (2019-11-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyResearch in context
by: Yousra Kherabi, et al.
Published: (2025-09-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Analysis of drug resistance among difficult-to-treat tuberculosis patients in Ghana identifies several pre-XDR TB cases
by: Isaac Darko Otchere, et al.
Published: (2023-01-01)

Delamanid in the Treatment of MDR/pre-XDR TB in Arkhangelsk Region in 2019–2021
by: E. S. Khimova, et al.
Published: (2023-07-01)

Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB
by: Natalia Zaporojan, et al.
Published: (2025-07-01)

Genomic characterization of MDR/XDR-TB in Kazakhstan by a combination of high-throughput methods predominantly shows the ongoing transmission of L2/Beijing 94–32 central Asian/Russian clusters
by: B. J. Klotoe, et al.
Published: (2019-06-01)

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)

Spinal Tuberculosis: An Exhaustive Diagnosis
by: Abhijit Acharya, et al.
Published: (2024-01-01)

The Emergence of Pott’s Disease in Complicated Systemic Sclerosis
by: Muhammad Luqman, et al.
Published: (2025-08-01)

New drugs and perspectives for new anti-tuberculosis regimens☆
by: S. Tiberi, et al.
Published: (2018-03-01)

Knowledge About Tuberculosis and Multi-Drug Resistant Tuberculosis Among Interns
by: Rupali A Patel, et al.
Published: (2014-03-01)

Activity of Semi-Synthetic Mulinanes against MDR, Pre-XDR, and XDR Strains of <i>Mycobacterium tuberculosis</i>
by: María Alejandrina Martínez-González, et al.
Published: (2021-12-01)

Issues of Tuberculosis Drug-Resistance in Kharkiv Region and in Ukraine
by: O.S. Shevchenko, et al.
Published: (2019-11-01)

Safety of chemotherapy of MDR/XDR-TB patients in high HIV prevalence settings
by: A. V. Kukurika, et al.
Published: (2022-12-01)

Drug-resistant tuberculosis: an experience from Qatar
by: Maisa Ali, et al.
Published: (2020-01-01)

Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience
by: Syed Beenish Rufai, et al.
Published: (2016-01-01)

Non‐contiguous multilevel spinal tuberculosis: A case report of unusual spinal tuberculosis resembling spinal metastasis
by: Salman Abbasi Fard, et al.
Published: (2023-03-01)

Spinal tuberculosis, pathophysiology and radiological presentation, three case reports
by: Vanessa M.S. Ross, et al.
Published: (2025-09-01)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
by: Cannas A, et al.
Published: (2019-10-01)

Extensively drug resistant tuberculosis in Mali: a case report
by: Bassirou Diarra, et al.
Published: (2017-11-01)

DIFFERENTIATION OF SPINAL TUBERCULOSIS AND METASTATIC SPINAL TUMOR USING MRI FEATURE: A SYSTEMATIC REVIEW
by: Justicia Izza Tsuroya, et al.
Published: (2023-01-01)

Global burden of MDR-TB and XDR-TB: trends, inequities, and future implications for public health planning
by: En-Li Tan, et al.
Published: (2025-10-01)

Pathogenesis, Diagnostic Challenges, and Risk Factors of Pott’s Disease
by: Ira Glassman, et al.
Published: (2023-01-01)

Comparing gene expression profiles of adults with isolated spinal tuberculosis to disseminated spinal tuberculosis identified by 18FDG-PET/CT at time of diagnosis, 6- and 12-months follow-up: classifying clinical stages of spinal tuberculosis and monitoring treatment response (Spinal TB X cohort study)
by: Julian Scherer, et al.
Published: (2024-06-01)

Diagnostic accuracy of the Xpert® MTB/XDR assay for detection of Isoniazid and second-line antituberculosis drugs resistance at central TB reference laboratory in Tanzania
by: Togolani Maya, et al.
Published: (2024-07-01)

Impact of Delayed Video-Assisted Thoracoscopic Surgery on Pneumonectomy Outcomes in Patients with Tuberculosis
by: D. B. Giller, et al.
Published: (2025-05-01)

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)

XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems
by: Monika Kozińska, et al.
Published: (2022-02-01)

Extensively Drug-Resistant Mycobacterium tuberculosis, India
by: Rajesh Mondal, et al.
Published: (2007-09-01)

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
by: Giuseppe Mancuso, et al.
Published: (2023-09-01)

Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort
by: Niccolò Riccardi, et al.
Published: (2024-01-01)